631
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin

, , , , , , & show all
Pages 482-491 | Accepted 01 Jul 2010, Published online: 04 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Donatella Panatto, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Paolo Bonanni, Sara Boccalini, Giancarlo Icardi, Roberto Gasparini & Daniela Amicizia. (2015) Evaluation of the economic burden of Herpes Zoster (HZ) infection. Human Vaccines & Immunotherapeutics 11:1, pages 245-262.
Read now
Hiltrud Liedgens, Marko Obradovic & Mark Nuijten. (2013) Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia. ClinicoEconomics and Outcomes Research 5, pages 597-609.
Read now
Chris M. Kozma, Carmela Benson, Terra L. Slaton, Myoung S. Kim & Gary J. Vorsanger. (2012) Opioids before and after initiation of pregabalin in patients with diabetic peripheral neuropathy. Current Medical Research and Opinion 28:9, pages 1485-1496.
Read now

Articles from other publishers (3)

Deborah Dowell, Kathleen R. Ragan, Christopher M. Jones, Grant T. Baldwin & Roger Chou. (2022) CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 . MMWR. Recommendations and Reports 71:3, pages 1-95.
Crossref
Jeffrey GudinJeffrey FudinElaine WangTodd HaylonKalpana PatelThomas F. Goss. (2019) Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia. Journal of Managed Care & Specialty Pharmacy 25:12, pages 1387-1396.
Crossref
Heidi J. Shannon, Julie Anderson & Jayant S. Damle. (2012) Evidence for Interventional Procedures as an Adjunct Therapy in the Treatment of Shingles Pain. Advances in Skin & Wound Care 25:6, pages 276-284.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.